Genmab
ABOUT US
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer and other serious diseases.
777 Scudders Mill Road
Bldg 2, Floor 4
Plainsboro, NJ 08536
(609) 430-2481
genmab.com
PRIMARY CONTACTS
Elizabeth Morse
Director, Federal National Accounts
(630) 386-1633
elmo@genmab.copm
Gia McLean
Associate Director, Health Evidence Outcomes Research
(640) 230-2647
gimc@genmab.com
PRODUCTS OR SERVICES
Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics.
For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.
PRODUCTS OR SERVICES
To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com and follow us on X.com/Genmab.
EPKINLY® (USA, Japan)
Epcoritamab
Disease area: Oncology